Yonsei University
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 160
- Registration Number
- NCT06268210
- Locations
- 🇰🇷
Severance hospital, Seoul, Korea, Republic of
The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) Study
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 52
- Registration Number
- NCT06260293
- Locations
- 🇰🇷
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
- Conditions
- Interventions
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 27
- Registration Number
- NCT06250777
- Locations
- 🇰🇷
Yonsei University Health system, Severance Hospital, Seoul, Korea, Republic of
AWARE Registry: Wearable ECG in Structural Heart Interventions
- Conditions
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 150
- Registration Number
- NCT06236776
- Locations
- 🇰🇷
Division of Cardiology, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea, Republic of
The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™)
- Conditions
- Interventions
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 140
- Registration Number
- NCT06237504
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 60
- Registration Number
- NCT06236789
- Locations
- 🇰🇷
Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, Republic of
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 100
- Registration Number
- NCT06234280
- Locations
- 🇰🇷
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
- Conditions
- Interventions
- First Posted Date
- 2024-01-30
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 2462
- Registration Number
- NCT06231966
- Locations
- 🇰🇷
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers
- Conditions
- First Posted Date
- 2024-01-30
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 4000
- Registration Number
- NCT06231953
- Locations
- 🇰🇷
Yonsei Cancer Center, Yonsei Univ. College of Medicine, Seoul, Korea, Republic of
Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment
- Conditions
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 100
- Registration Number
- NCT06221657